id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2003-N-0385-0243,FDA,FDA-2003-N-0385,FDA,Notice,NEC-Notice of Extension,2007-04-03T04:00:00Z,2007,4,2007-04-02T04:00:00Z,2007-05-04T03:59:59Z,2008-04-12T01:05:36Z,,0,0,090000648049cd7e
FDA-2003-N-0385-0067,FDA,FDA-2003-N-0385,"FDA To Hon. Peter J. Visclosky, House of Representatives",Other,LET-Letter,2007-03-21T04:00:00Z,2007,3,,,2008-04-12T01:08:02Z,,0,0,090000648049c8ca
FDA-2003-N-0385-0234,FDA,FDA-2003-N-0385,FDA/CVM,Other,SUP-Supplement,2007-01-17T05:00:00Z,2007,1,,,2008-04-12T01:04:08Z,,0,0,090000648049c0ba
FDA-2003-N-0385-0230,FDA,FDA-2003-N-0385,FDA/CVM,Other,SUP-Supplement,2007-01-17T05:00:00Z,2007,1,,,2008-04-12T01:06:41Z,,0,0,090000648049c0b8
FDA-2003-N-0385-0225,FDA,FDA-2003-N-0385,FDA/CVM,Other,SUP-Supplement,2007-01-17T05:00:00Z,2007,1,,,2008-04-12T01:06:41Z,,0,0,090000648049c0aa